Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

TASE:ARD
TASE:ARDElectronic

Arad (TASE:ARD) Net Profit Margin Improves to 6.7%, Reinforcing Bullish Profitability Narrative

Arad (TASE:ARD) just posted its Q3 2025 results, reporting total revenue of $110.6 million and basic EPS of $0.369, with net income (excluding extra items) at $9.1 million. The company has seen revenue move from $98.2 million in Q1 2024 to $97.3 million in Q2 2024, then up to the recent $110.6 million in Q3 2025. EPS rose from $0.276 in Q1 2024 to $0.369 in Q3 2025. Healthy margins remained in focus throughout these periods, reinforcing the steady profitability picture for investors. See our...
OM:SUS
OM:SUSMedical Equipment

Why Surgical Science Sweden (OM:SUS) Is Down 54.0% After Intuitive Cancels Key Licensing Agreement

In late November 2025, Surgical Science Sweden AB announced that Intuitive canceled their Memorandum of Understanding and shifted back to their prior agreement, with the company warning it will not meet its previously stated 2026 financial targets. This decision is projected to reduce Surgical Science Sweden’s license revenues by approximately SEK 60–90 million in 2026, highlighting the company’s exposure to fluctuations in large partner relationships. To assess the impact of Intuitive’s...
HLSE:STERV
HLSE:STERVForestry

What Stora Enso’s Recent 4.9% Rally Means for Its True Value in 2025

Curious whether Stora Enso Oyj is undervalued, overvalued, or priced just right? You are not alone. Let's dig into what the numbers are telling us. The stock has seen a solid 4.9% gain over the past week and a 14.3% return in the last year, giving investors fresh reasons to revisit its long-term potential. Markets have been paying attention, with recent headlines highlighting the company's continued transformation efforts and strategic investments in sustainable packaging solutions. This...
SEHK:1860
SEHK:1860Media

Mobvista (SEHK:1860) Valuation in Focus After Sales Jump and Swing to Net Loss

Mobvista (SEHK:1860) just released its third quarter earnings, revealing a jump in sales compared to last year. However, investors are weighing the shift from net profit to net loss over the same period. See our latest analysis for Mobvista. Mobvista’s 1-day share price return of 5.09% shows investors reacting quickly to the earnings headlines. This follows a sharp 18.5% decline over the past week. Despite recent volatility, the stock’s year-to-date price gain of 112.92% and robust 83.38%...
TSE:9531
TSE:9531Gas Utilities

Evaluating Tokyo Gas After 18% Monthly Surge and Renewable Energy Expansion News

Ever wondered if Tokyo GasLtd's strong performance means it is still good value, or if it's already priced to perfection? You're not alone. Let's dig in to see what's really going on. The stock has jumped 4.1% in the past week and a remarkable 18.1% over the last month, building on a stellar 44.4% year-to-date return and an impressive 43.0% gain over the last 12 months. Recent headlines have zoomed in on Tokyo GasLtd's expansion plans, highlighting partnerships in renewable energy and a push...
TASE:MDTR
TASE:MDTRHealthcare

Mediterranean Towers (TASE:MDTR) Net Profit Surges on One-Off Gain, Raising Questions About Sustainability

Mediterranean Towers (TASE:MDTR) just posted its Q2 2025 results, reporting total revenue of ₪68.2 million and basic EPS of ₪0.61. Looking back, the company saw revenue increase from ₪61.4 million in Q2 2024 to ₪68.2 million in Q2 2025, with basic EPS advancing from ₪0.18 to ₪0.61 over the same stretch. These headline numbers come amid notably high margins, setting the stage for investors to weigh the sustainability of such profitability. See our full analysis for Mediterranean Towers. Now,...
TASE:ANLT
TASE:ANLTCapital Markets

I.M.S. Investment (TASE:ANLT) Net Margin Boost Reinforces Bull Case, but One-Off Gain Drives Result

Analyst I.M.S. Investment Management Services (TASE:ANLT) just posted its Q3 2025 results, reporting total revenue of ₪117.9 million and basic EPS of ₪2.79. Looking back, the company has seen revenue move from ₪76.9 million in Q2 2024 up to the latest figure, while EPS advanced from ₪0.51 to ₪2.79 over the same period. Expanding profit margins and headline net income have put investor focus on the quality behind ANLT’s numbers this quarter. See our full analysis for Analyst I.M.S. Investment...
NasdaqGM:TMDX
NasdaqGM:TMDXMedical Equipment

Is Now the Right Time for TransMedics After a 120% Surge and FDA Approvals?

Curious if TransMedics Group is still a bargain or if the huge price moves have put it out of reach? Let’s break down whether now is the right time to buy in or stay on the sidelines. TransMedics stock has soared 120.0% year-to-date and 68.7% over the past year, drawing fresh attention from growth investors and those tracking emerging medical technology trends. Much of this renewed interest follows industry headlines about innovations in organ transplant logistics and successful expansion...